These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26952695)

  • 1. Schneiderian first rank symptoms in schizophrenia: A developmental neuroscience evaluation.
    Tikka SK; Nizamie SH; Das AK; Agarwal N; Goyal N
    Int J Dev Neurosci; 2016 May; 50():39-46. PubMed ID: 26952695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Adjunctive Θ Burst Repetitive Transcranial Magnetic Stimulation to Right Inferior Parietal Lobule in Schizophrenia Patients With First-Rank Symptoms: A Pilot, Exploratory Study.
    Tikka SK; Nizamie SH; Venkatesh Babu GM; Aggarwal N; Das AK; Goyal N
    J ECT; 2017 Mar; 33(1):43-51. PubMed ID: 27428476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of spontaneous dense array gamma oscillatory activity and minor physical anomalies as a composite neurodevelopmental endophenotype in schizophrenia.
    Tikka SK; Nizamie SH; Goyal N; Pradhan N; Tikka DL; Katshu MZ
    Int J Dev Neurosci; 2015 Feb; 40():43-51. PubMed ID: 25450528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schneiderian first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naïve schizophrenia.
    Venkatasubramanian G; Jayakumar PN; Keshavan MS; Gangadhar BN
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):40-6. PubMed ID: 20688126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schneiderian first rank symptoms and gamma oscillatory activity in neuroleptic naïve first episode schizophrenia: a 192 channel EEG study.
    Tikka SK; Yadav S; Nizamie SH; Das B; Tikka DL; Goyal N
    Psychiatry Investig; 2014 Oct; 11(4):467-75. PubMed ID: 25395979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological brain activity and antisaccade performance in schizophrenia patients with first-rank (passivity) symptoms.
    Waters F; Price G; Dragović M; Jablensky A
    Psychiatry Res; 2009 Dec; 170(2-3):140-9. PubMed ID: 19906434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.
    Song X; Fan X; Li X; Kennedy D; Pang L; Quan M; Chen X; Gao J; Zhang W; Zhang J; Lv L
    Schizophr Res; 2014 Oct; 159(1):51-5. PubMed ID: 25128453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
    Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shall we really say goodbye to first rank symptoms?
    Heinz A; Voss M; Lawrie SM; Mishara A; Bauer M; Gallinat J; Juckel G; Lang U; Rapp M; Falkai P; Strik W; Krystal J; Abi-Dargham A; Galderisi S
    Eur Psychiatry; 2016 Sep; 37():8-13. PubMed ID: 27429167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased spontaneous gamma power and synchrony in schizophrenia patients having higher minor physical anomalies.
    Tikka SK; Nizamie SH; Das B; Katshu MZ; Goyal N
    Psychiatry Res; 2013 May; 207(3):164-72. PubMed ID: 23051885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients.
    Suazo V; Lubeiro A; Jurado-Barba R; Moreno-Ortega M; Dompablo M; Morales-Muñoz I; Rodriguez-Jimenez R; Palomo T; Molina V
    Eur Arch Psychiatry Clin Neurosci; 2016 Dec; 266(8):743-753. PubMed ID: 26831320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome.
    Lin CC; Hung YY; Tsai MC; Huang TL
    Medicine (Baltimore); 2017 Jun; 96(22):e7089. PubMed ID: 28562580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting State Dense Array Gamma Oscillatory Activity as a Response Marker for Cerebellar-Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia.
    Tikka SK; Garg S; Sinha VK; Nizamie SH; Goyal N
    J ECT; 2015 Dec; 31(4):258-62. PubMed ID: 25923998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
    Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial distribution and cognitive correlates of gamma noise power in schizophrenia.
    Díez A; Suazo V; Casado P; Martín-Loeches M; Molina V
    Psychol Med; 2013 Jun; 43(6):1175-85. PubMed ID: 22963867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.